News

The good news for patients is that GA is transitioning from an untreatable disease to a potentially treatable one with development of new therapies to reduce the growth rate, and use of anti-complement therapies have caused the growth rate of GA lesions to decrease.

When we discuss trial participation with patients, we stress that the goal of these studies is to obtain better visual outcomes and ease the treatment burden.

According to the foundation, the grants were awarded to 18 investigators at prominent universities in the United States, Nigeria, and Hong Kong.

At this year's Congress on Controversies in Ophthalmology, keynote speaker Ursula Schmidt-Erfurth, MD, addressed the clinical use of artificial intelligence

Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.

According to the company, its Virtual Eye Pro features improve visual field testing for practice and patients.

The trial evaluated nesvategrast (OTT166 5%) eye drops in patients with diabetic retinopathy.

The trial evaluated nesvategrast (OTT166 5%) eye drops in patients with diabetic retinopathy.

The reverse stock split is “part of the Company’s plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market."

Patients who underwent LASIK had undergone phacoemulsification 7 years earlier compared to a matched control group, according to the study authors.

Advances in virtual reality and AI are helping those with AMD and low vision.

Even small changes can have a large impact, saving time for physicians.

Research indicates smoking increases risk of AMD, cataracts and glaucoma

Study demonstrates that patients achieved long-term visual acuity gains following CureSight treatment.

OCU410 is a modifier gene therapy candidate being developed for geographic atrophy, an advanced stage of dry age related macular degeneration.

Scientists at the Doheny Eye Institute, in collaboration with UCLA chemists, demonstrate how a single gene mutation in an enzyme complex known to produce the energy required by cells causes a sudden, blinding disease.

The transient receptor potential melastatin 8 (TRPM8) are cold-sensitive thermoreceptors that play central role in tear film homeostasis

The Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.

The collaboration combines Clario's transformative technology with Cleveland Clinic's market-leading imaging expertise and AI-enabled analysis to help bring new therapies to patients, faster.

Ferrone’s role will be effective as of March 18, 2024.

Ophthalmologists can educate their patients about the importance of using certified solar viewing glasses or other safe viewing methods.

Vermont is the latest state to consider legislation expanding the scope of practice for optometrists. Earlier this year, South Dakota became the 12th state to expand the scope of practice for optometrists.

The organization aims to educate viewers of dangers and safety precautions ahead of the eclipses.

LL-BMT1 is a novel, preservative-free, weekly drug-eluting contact lens created by the company’s proprietary 3D printing technology.

Cyclosporine superior to vehicle, improves corneal staining in dry eye disease

Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation

Investigators emphasized that the data does not indicate a causal relationship between eye disorder and systemic diseases.

In the study, published in Nature Biotechnology, researchers used their new system to correct disease-causing mutations in the eyes of two mouse models of genetic blindness, partially restoring their vision.